Sinonasal malignancy: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
Carlo Resteghini, B. Baujat, Paolo Bossi, Alessandro Franchi, L. de Gabory, Jana Halámková, Frank Haubner, José A. Hardillo, Mario Hermsen, Nicola Alessandro Iacovelli, Roberto Maroldi, Stefan Mattheis, Antoine Moya‐Plana, Piero Nicolai, Ester Orlandi, Juliette Thariat, Annalisa Trama, Michiel W. M. van den Brekel, Carla M.L. van Herpen, Benjamin Vérillaud, E. Kinloch, Lisa Licitra, Caroline Even
Abstract
• The CPG provides key recommendations and algorithms for managing SMs, excluding mucosal melanoma and soft-tissue sarcomas. • The guideline covers diagnosis, staging, risk assessment, treatment and disease monitoring. • Technological advancements in treatment with RT are discussed with a special focus on particle therapy. • Surgical indications for open and transnasal endoscopic surgery are provided. • Neoadjuvant chemotherapy in high-grade, locally advanced SMs helps to select subjects for conservative treatments.